WEISMAN HOWARD J. (Chief Executive Officer) sold 1.0% of their position (372.00 shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $174.84 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2024ACC: 0001104659-24-008883
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-372.00
Net shares
Net seller
$174.84
Total sold
1
Open market trades
0B · 1S
1
Total transactions
372.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−372.00
Price / share
$0.47
Trade value
$174.84
% of position
1.0%
1/29/2024
38.05K→37.67K
Total
Net shares
−372.00
Net value
-$174.84
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2024 | S · Sale | −372.00 | $0.47 | $174.84 | 1.0% | 38.05K | 37.67K |
| Total | −372.00 | -$174.84 | ||||||
Derivative Transactions0
No derivative transactions reported